Form 4: ReposiTrak CEO Randall K. Fields Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
ReposiTrak's CEO, Randall K. Fields, executed sales of common stock under a pre-arranged Rule 10b5-1 trading plan to meet charitable commitments.
Summary
- Randall K. Fields, CEO of ReposiTrak, Inc. (TRAK), reported changes in beneficial ownership of the company's stock.
- On March 3, 2025, Fields sold 4,000 shares of common stock at a weighted average price of $19.5831 per share.
- On March 4, 2025, he sold an additional 3,500 shares at a weighted average price of $19.4536 per share.
- These sales were executed automatically under a Rule 10b5-1 trading plan adopted by Fields in his capacity as Trustee of the 2022 RK Fields Charitable Remainder Unitrust.
- The trading plan was established to meet some of his charitable commitments.
- Following these transactions, Fields directly owns 3,683,955 shares of common stock.
- He also indirectly owns shares through various entities, including RK Fields Charitable 2022, LLC (282,000 shares), Riverview Financial Corp. (615,260 shares of common stock and 531,432 shares of Series B Preferred Stock), his spouse (30,667 shares of common stock and 12,322 shares of Series B Preferred Stock), and Fields Management, Inc. (333,643 shares).
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing reporting insider transactions. The sales are explained as part of a pre-arranged plan for charitable giving, which mitigates potential negative sentiment. Overall, the sentiment is neutral.
Risks
- Sales by insiders, even under pre-arranged plans, can sometimes be perceived negatively by the market.
Industry Context
Insider transactions are routinely monitored and reported, providing transparency to investors. Rule 10b5-1 plans are a common mechanism for insiders to sell shares without raising concerns about trading on non-public information.
Stakeholder Impact
- The share sales could have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Sale of 4,000 shares of common stock at a weighted average price of $19.5831. |
| 03/04/2025 | Sale of 3,500 shares of common stock at a weighted average price of $19.4536. |
| 03/04/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.